{"brief_title": "Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "brief_summary": "The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple dose inhaler for use in the COPD Phase III program.", "condition": "COPD", "intervention_type": "Drug", "intervention_name": "QAB149", "criteria": "Inclusion Criteria: - Diagnosis of COPD - Age 40-75 years - Smoking history Exclusion Criteria: - Other serious disease - Allergy to QAB149 - Respiratory tract infection", "gender": "All", "minimum_age": "40 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "id": "NCT00098228.xml"}